Dr. Dominik Schaffner
Dr. Dominik Schaffner is a medical practitioner based in Sydney, fully accredited in Australia, Germany, and the EU. His main focus and expertise lie in regenerative medicine, longevity medicine, biologics, orthopaedics, and musculoskeletal trauma. He is a German board-certified Specialist Orthopaedic and Musculoskeletal Trauma Surgeon.
Speciality
Practicing regenerative and longevity medicine, integrating cutting-edge therapies to optimize health, performance, and recovery
Regenerative Medicine
Regenerative medicine focuses on activating the body’s innate ability to repair and renew itself at the cellular level. Through advanced modalities such as stem cells, PRP, exosomes, and tissue engineering, it supports healing, reduces inflammation, and enhances resilience. This field represents a shift from managing symptoms to restoring function—targeting the root cause of degeneration to promote long-term vitality and recovery.
Longevity Medicine
Longevity medicine is a data-driven, preventative approach to health that aims to extend healthspan—the years lived in optimal physical and cognitive condition. It combines personalised diagnostics, biomarker tracking, advanced imaging, and molecular optimisation to detect early signs of decline and intervene before disease develops. This represents the foundation of Medicine 3.0—a proactive, precision-based model that focuses on prevention, performance, and sustainable well-being.
Orthopaedics & Trauma
Contemporary orthopaedic and trauma care integrates surgical precision with biologics and functional restoration. It addresses musculoskeletal injuries, joint degeneration, and soft tissue damage using a combination of operative techniques and regenerative therapies. With treatments such as PRP, stem cells, and targeted rehabilitation, the focus is not only on recovery—but on optimising mobility, performance, and long-term musculoskeletal health.
15+ years of international experience across state-of-the-art centres of care
About
Dr. Dominik Schaffner is a German-Australian medical practitioner, fully accredited in both Germany and Australia
Dr. Dominik Schaffner is a German-Australian medical practitioner, fully accredited in both Germany and Australia, with extensive expertise in regenerative medicine, longevity medicine, and orthopaedic surgery. His clinical and research background spans Germany, the European Union, South Africa, Australia, and the Asia-Pacific region, with a substantial focus on cartilage regeneration, as well as interests in PRP, stem cells, exosomes, and biologics. A former professional sailor who represented the Federal Republic of Germany in the 49er class, he possesses deep knowledge of athletic performance and human optimisation. His main focus in Australia and the Asia-Pacific region is Medicine 3.0, advancing regenerative and longevity medicine. Dr. Schaffner has held academic appointments with both the University of New South Wales (UNSW) and the Technical University of Munich, and has been actively involved in medical student training and lecturing in orthopaedics and regenerative medicine. He is also a keynote speaker at international regenerative medicine, longevity, and orthopaedic conferences, sharing insights on the future of human health and performance. He currently also serves as an International Fellow & Locum Staff Specialist in Australia, and holds locum positions in the UAE and EU as an orthopaedic and musculoskeletal trauma surgeon. He practices regenerative and longevity medicine, integrating cutting-edge therapies to optimise health, performance, and recovery.
Interests and expertise
Platelet-Rich Plasma (PRP), stem cells, and exosomes represent the frontier of regenerative medicine. These biologic therapies are designed to enhance the body's natural healing processes by promoting cellular repair, reducing inflammation, and stimulating tissue regeneration. While global research continues to evolve rapidly, access to these advanced treatments may vary depending on local regulations.
Biologics and orthobiologics refer to naturally derived substances—such as growth factors, proteins, and cells—used to support the healing of musculoskeletal injuries. These therapies are gaining attention for their potential to reduce the need for invasive procedures and to improve outcomes in joint, tendon, and cartilage care.
Tissue engineering combines scaffolds, biologics, and cellular science to encourage the body to regenerate damaged structures. Bone marrow stimulation techniques, such as microfracture, aim to release stem cells to aid in cartilage and bone repair. These innovative approaches are shaping the future of personalized orthopedic and regenerative care.
Cartilage damage is notoriously difficult to heal due to its limited blood supply. Regenerative strategies—including biologic injections, scaffold implants, and cellular therapies—are being explored globally to help restore joint function, delay degeneration, and potentially avoid joint replacement surgery.
Successful integration between bone and implants is critical for long-term success in joint replacement and orthopedic hardware. Research in this field focuses on improving implant surfaces and biological compatibility to enhance stability, reduce failure rates, and support faster recovery.
Artificial Intelligence (AI) is transforming healthcare by enabling earlier diagnoses, personalized treatment plans, and predictive insights. In regenerative and longevity medicine, AI tools are being developed to analyze biomarkers, track recovery, and optimize patient outcomes with data-driven precision.
Peptides are short chains of amino acids that act as signaling molecules in the body. Emerging peptide therapies are being studied for their role in promoting healing, regulating hormones, improving skin health, enhancing cognitive function, and supporting immune resilience. While access is evolving, peptide science represents a promising area of personalized medicine.